Use of Zeranol to modulate reproductive cycles

• US 6,087,352 A
• Filed: 08/16/1999
• Issued: 07/11/2000
• Est. Priority Date: 08/17/1998
• Status: Expired due to Fees

• Current Assignee: William E. Trout
• Original Assignee: William E. Trout
• Inventors: Trout, William E.
• Primary Examiner(s): HENLEY III, RAYMOND J
• Application Number:
  US09/374,776
• Time in Patent Office: 330 Days
• Field of Search: 514/178
• US Class Current: 514/178
• CPC Class Codes: A61K 2300/00 Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
• CPC Class Codes: A61K 31/365 Lactones
• CPC Class Codes: A61K 31/557 Eicosanoids, e.g. leukotrienes or prostaglandins
• CPC Class Codes: A61K 38/24 Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
• CPC Class Codes: A61K 45/06 Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

Abstract

This invention relates to a method for modulating the function of the reproductive system in female animals, especially farm animals, and specifically in horses and pigs, by administering an effective amount of zeranol. Specifically, this invention provides a method for maintaining corpus luteum function, especially in pigs and horses, by administering an effective amount of zeranol.

Claims

1. A method for modulating a function of a female reproductive system comprising administration to a female animal of an effective amount of a composition comprising zeranol.

2. The method of claim 1 wherein the function of the female reproductive system comprises corpus luteum function, progesterone secretion, progesterone synthesis, induction of pseudopregnancy, maintenance of pregnancy, onset of puberty, maturation of the uterus, maintenance of uterine endometrium, return to estrus, onset of fertility, maintenance of fertility, return to fertility following lactation, return to fertility following parturition, decrease in durations of infertile periods, and summer infertility.

3. The method of claim 1, wherein the female animal is a domestic animal, a farm animal or a laboratory animal.

4. The method of claim 1, wherein the female animal is a pig, feral pig, peccary, horse, bear, hippopotamus, lion, tiger, elephant, rhinoceros, rat, mouse, hamster, guinea pig, cat, sheep, or cow.

5. The method of claim 1, wherein the female animal is a pig or a horse.

6. The method of claim 1, wherein the administration comprises parenteral, topical, or oral administration.

7. The method of claim 1, wherein the effective amount of the composition is between approximately 0.01 mg and 800 mg of zeranol and is administered as an implant.

8. The method of claim 1, wherein the female animal is a pig and the effective amount of the composition is between approximately 0.01 mg and 150 mg of zeranol and is administered as an implant.

9. The method of claim 1, wherein the effective amount of the composition is between approximately 0.1 mg and 5000 mg of zeranol and is administered orally.

10. The method of claim 1, wherein the female animal is a pig, the administration is oral, and the effective amount of the composition is an amount is between approximately 0.1 mg and 1000 mg of zeranol.

11. The method of claim 1 further comprising administration of one or more substances selected from the group consisting of prostaglandin, prostaglandin F₂ α

, luteinizing hormone, follicle stimulating hormone, gonadotropin, pregnant mare'"'"'s serum gonadotropin, chorionic gonadotropin, human chorionic gonadotropin, equine chorionic gonadotropin, gonadotropin releasing hormone, neuropeptide Y, estrogen, progesterone, analogs thereof, and combinations thereof.

12. The method of claim 1 further comprising administration of gonadotropin prior to zeranol administration and prostaglandin administration after zeranol administration.